BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2203881)

  • 1. A model of gastric emptying in cats shows solid emptying is promoted by MK-329: a CCK antagonist.
    Gould RJ; Fioravanti C; Cook PG; Solomon HF
    J Nucl Med; 1990 Sep; 31(9):1494-9. PubMed ID: 2203881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric emptying of solid radiopaque markers: studies in healthy subjects and diabetic patients.
    Feldman M; Smith HJ; Simon TR
    Gastroenterology; 1984 Oct; 87(4):895-902. PubMed ID: 6468877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of MK-329 on gastric emptying of solids in cats.
    Hornof WJ; Koblik PD
    J Nucl Med; 1991 Mar; 32(3):547-8. PubMed ID: 2005467
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat.
    Decktor DL; Pendleton RG; Elnitsky AT; Jenkins AM; McDowell AP
    Eur J Pharmacol; 1988 Mar; 147(2):313-6. PubMed ID: 3366182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous cholecystokinin in the control of gastric emptying of liquid nutrient loads in rhesus monkeys.
    Moran TH; Ameglio PJ; Schwartz GJ; Peyton HJ; McHugh PR
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R371-5. PubMed ID: 8368391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voluntary intake and gastric emptying in pigs: effects of fat and a CCK inhibitor.
    Rayner DV; Miller S
    Physiol Behav; 1993 Nov; 54(5):917-22. PubMed ID: 8248383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of solid- and liquid-phase gastric emptying half times in cats by use of nuclear scintigraphy.
    Costello M; Papasouliotis K; Barr FJ; Gruffydd-Jones TJ; Caney SM
    Am J Vet Res; 1999 Oct; 60(10):1222-6. PubMed ID: 10791934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline cholescintigraphy. Studies on role of cholecystokinin in regulation of gallbladder function.
    Niewiarowski T; Maurer AH; Fisher RS; Krevsky B
    Dig Dis Sci; 1990 Sep; 35(9):1098-104. PubMed ID: 2390924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric emptying of a physiologic mixed solid-liquid meal.
    Fisher RS; Malmud LS; Bandini P; Rock E
    Clin Nucl Med; 1982 May; 7(5):215-21. PubMed ID: 7083695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
    Green T; Dimaline R; Peikin S; Dockray GJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
    Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
    Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C
    Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravenous diazepam on solid phase gastric emptying in normal cats.
    Steyn PF; Twedt D; Toombs W
    Vet Radiol Ultrasound; 1997; 38(6):469-73. PubMed ID: 9402716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids.
    Urbain JL; Vantrappen G; Janssens J; Van Cutsem E; Peeters T; De Roo M
    J Nucl Med; 1990 Sep; 31(9):1490-3. PubMed ID: 2395017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbid obesity treated by gastroplasty: radionuclide gastric emptying studies.
    Arnstein NB; Shapiro B; Ekhauser FE; Dmuchowski CF; Knol JA; Strodel WE; Nakajo M; Swanson DP
    Radiology; 1985 Aug; 156(2):501-4. PubMed ID: 3892581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of solid-phase labels for gastric emptying studies in cats.
    Hoskinson JJ; Goggin JM; Butine MD
    J Nucl Med; 1997 Mar; 38(3):495-9. PubMed ID: 9074547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of nicotine patch on gastric emptying of liquid and solid contents in healthy subjects.
    Wong PW; Kadakia SC; McBiles M
    Dig Dis Sci; 1999 Nov; 44(11):2165-71. PubMed ID: 10573358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the cholecystokinin antagonist devazepide (L364718) on the ileal brake mechanism in the rat.
    Brown NJ; Rumsey RD; Read NW
    J Pharm Pharmacol; 1993 Dec; 45(12):1033-6. PubMed ID: 7908970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.